(−)-N-Hydroxyapiosporamide | MedChemExpress (MCE)
(−)-N-Hydroxyapiosporamide (NHAP), an alkaloid, is an NF-κB inhibitor with potent antitumor activity in vitro and in vivo. (−)-N-Hydroxyapiosporamide can be used for the research of colorectal cancer (CRC)[1].
| Trivial name | (−)-N-Hydroxyapiosporamide |
| Catalog Number | HY-N11777 |
| Alternative Name(s) | NHAP |
| Research Area | Cancer |
| CAS# | 1205676-02-3 |
| Purity | ≥98.00% |
| SMILES | O=C([C@]1([C@]2([C@@]([H])(C[C@@H](CC2)C)C=C[C@H]1C)[H])[H])C3=C(C([C@@]4([C@H]5[C@@H]([C@@H](CC4)O)O5)O)=CN(O)C3=O)O |
| PubChem Chemical Structure ID | 132504557 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/n-hydroxyapiosporamide.html |